Effect of repeated treatment with topiramate on the beta-endorphin plasma level in rats selectively bred for high and low alcohol preference

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 2, 2007, Pages 525-528

  Zalewska Kaszubska, Jadwiga ^a   Gorska, Dorota ^a   Dyr, Wanda ^b   Czarnecka, Elzbieta ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Alcohol preferring rats; Beta endorphin; Ethanol; Topiramate

Indexed keywords

4 AMINOBUTYRIC ACID; ALCOHOL; BETA ENDORPHIN; CARBONATE DEHYDRATASE; GLUTAMIC ACID; OPIATE; TOPIRAMATE; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL;

ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; FEMALE; GABAERGIC TRANSMISSION; GENETIC PREDISPOSITION; NEUROTRANSMISSION; NONHUMAN; PROTEIN BLOOD LEVEL; RAT;

ALCOHOLISM; ANIMALS; BETA-ENDORPHIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FRUCTOSE; NEUROPROTECTIVE AGENTS; RADIOIMMUNOASSAY; RATS;

EID: 33846781328     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.12.002     Document Type: Article

References (22)

1. Angehagen M., Ben-Menachem E., Shank R., Ronnback L., and Hansson E. Topiramate modulation of kainite-induced calcium currents is inversely related to channel phosphorylation level. J Neurochem 88 (2004) 320-325
2. Angehagen M., Ronnback L., Hansson E., and Ben-Menachem E. Topiramate reduces AMPA-induced Ca(2+)transients and inhibits GluR1 subunit phosphorylation in astrocytes from primary cultures. J Neurochem 94 (2005) 1124-1130
3. Angwin P., and Barchas J.D. Use of silicic acid extraction and reversed-phase columns for rapid purification prior to radioimmunoassay. J Chromatogr 231 (1982) 173-177
4. Berlant J., and van Kammen D.P. Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report. J Clin Psychiatry 63 (2002) 15-20
5. Cagetti E., Baicy K.J., and Olsen R.W. Topiramate attenuates withdrawal signs after chronic intermittent ethanol in rats. NeuroReport 15 (2004) 207-210
6. Dodgson S.J., Shank R.P., and Maryanoff B.E. Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 41 Suppl 1 (2000) S35-S39
7. Follett P.L., Deng W., Dai W., Talos D.M., Massillon L.J., Rosenberg P.A., et al. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci 24 (2004) 4412-4420
8. Gabriel K.I., and Cunningham C.L. Effects of topiramate on ethanol and saccharin consumption and preferences in C57BL/6J mice. Alcohol Clin Exp Res 29 (2005) 75-80
9. Gianoulakis C., Beliveau D., Angelogianni P., Meaney M., Thavundayil J., Tawar V., et al. Different pituitary beta-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholism. Life Sci 45 (1989) 1097-1109
10. Gryder D.S., and Rogawski M.A. Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdale neurons. J Neurosci 23 (2003) 7069-7074
11. Hoffman L., Burges Watson P., Wilson G., and Montgomery J. Low plasma beta-endorphin in post-traumatic stress disorder. Aust N Z J Psychiatry 23 (1989) 269-273
12. Johnson B.A., Ait-Daoud N., Akhtar F.Z., and Ma J.Z. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial. Arch Gen Psychiatry 61 (2004) 905-912
13. Khan S., and Liberzon I. Topiramate attenuates exaggerated acoustic startle in an animal model of PTSD. Psychophrmacology (Berl) 172 (2004) 225-229
14. Kiefer F., Horntrich M., Jahn H., and Wiedemann K. Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency?. Psychopharmacology 162 (2002) 433-437
15. Rustembegovic A., Sofic E., and Kroyer G. A pilot study of Topiramate (Topamax) in the treatment of tonic-clonic seizures of alcohol withdrawal syndromes. Med Arh 56 (2002) 211-212
16. Volpicelli J., Balaraman G., Hahn J., Wallace H., and Bux D. The role of uncontrollable trauma in the development of PTSD and alcohol addiction. Alcohol Res Health 23 (1999) 256-262
17. White H.S., Brown S.D., Woodhead J.H., Skeen G.A., and Wolf H.H. Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia 41 Suppl 1 (2000) S17-S20
18. Zalewska-Kaszubska J., and Czarnecka E. Deficit in beta-endorphin peptide and tendency to alcohol abuse. Peptides 26 (2005) 701-705
19. Zalewska-Kaszubska J., and Obzejta D. Use of low-energy laser as adjunct treatment of alcohol addiction. Lasers Med Sci 19 (2004) 100-104
20. Zalewska-Kaszubska J., Cwiek W., Dyr W., and Czarnecka E. Changes in the beta endorphin plasma level after repeated treatment with acamprosate in rats selectively bred for high and low alcohol preference. Neurosci Lett 388 (2005) 45-48
21. Zona C., Ciotti M.T., and Avoli M. Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells. Neurosci Lett 231 (1997) 123-126
22. Zullino D.F., Khazaal Y., Hattenschwiler J., Borgeat F., and Besson J. Anticonvulsant drugs in the treatment of substance withdrawal. Drugs Today (Barc) 40 (2004) 603-619